【摘要】目的 探讨亚急性甲状腺炎的诊断和治疗。 方法 回顾性分析吉林大学中日联谊医院1962年1月至2000年1月期间收治的372例亚急性甲状腺炎患者的临床资料。结果 372例亚急性甲状腺炎中129例误诊为其他甲状腺疾病，6例合并甲状腺乳头状癌。183例在发病前有上呼吸道感染病史，235例颈前区疼痛，348例发现颈前区包块，45例合并乙型肝炎病毒感染。 行彩色多普勒检查、甲状腺核素扫描检查、甲状腺吸131Ⅰ率测定及细针穿刺细胞学检查，其阳性率分别为95.62%、89.66%、69.70%及89.41%，T3、T4及TSH指标也有不同程度改变。107例患者行激素加甲状腺素治疗，133例行口服肠溶阿斯匹林连续2个月以上治疗，部分患者加服优甲乐100 μg/d。135例行手术治疗。 结论 无上呼吸道感染病史和无颈前区疼痛的亚急性甲状腺炎病例易误诊为其他甲状腺疾病。彩色多普勒、细针穿刺细胞学检查诊断率高，特异性强，是首选的检查手段； 甲状腺核素扫描可以准确地反映甲状腺功能状态； 检测血清中T3、T4及TSH水平可以协助诊断本病，判断疾病所处阶段。口服肠溶阿斯匹林加用优甲乐治疗本病效果良好。
Objective To investigate appropriate treatment strategy and timing for patients with subacute myocardial infarction and severe ischemic mitral regurgitation （IMR）. Methods A total of 89 patients with subacute myocardial infarction and severe IMR underwent surgical treatment from January 2005 to December 2011 in Beijing Anzhen Hospital. There were 66 male patients and 23 female patients with their mean age of 64 （55-73） years. All the patients received only coronary artery bypass grafting （CABG） after 3 months of medication treatment without specific management for their IMR. Echocardiography was examined before medication treatment，preoperatively and 6 months after CABG to analyze their IMR degree and measure left ventricular end-systolic dimension （LVESD），left ventricular end diastolic dimension （LVEDD） and left ventricular ejection fraction （LVEF）. Results There was no surgery-related death，perioperative myocardial ischemia or other severe postoperative complication. Eighty-one patients （91.0%） were followed up for 6-60 months. At 6 months after CABG，mitral regurgitation area （3.1±1.3 cm2 vs. 5.6±2.3 cm2），LVEDD （51.3±4.2 mm vs. 54.3±5.5 mm） and LVESD （31.7±3.9 mm vs. 34.6±4.3 mm） were significantly decreased than preoperative values （P＜0.05），but LVEF was not statistically different from preoperative value （59.1%±3.9% vs. 58.9%±5.6%，P＞0.05）. From the third year during follow-up，all the patients received annual CT examination of their coronary artery，and no significant graft stenosis （graft stenosis＞50%） was found. Conclusion With appropriately delayed CABG and right medication treatment，patients with subacute myocardial infarction and severe IMR may no longer need concomitant surgical management for their IMR， which can decrease surgical risks and reduce treatment cost.
【摘要】 目的 评价切开复位Herbert螺钉内固定加外支架治疗对亚急性和陈旧性舟状骨骨折的治疗效果。方法 2008年2月—2009年5月,对15例受伤后4周以上(平均7.6周)入院诊断为亚急性和陈旧性舟状骨骨折的患者均采用Herbert螺钉内固定加外支架治疗,术后随访5～16个月,平均12.5个月,按Gartland amp; Werley和改良Green amp; O’Brein评分系统进行评价治疗效果。结果 15例患者均进行有效随访,末次随访Gartland amp; Werley评分优8例,良5例,中2例,优良率为86.7％,改良Green amp; O’Brein评分优7例,良5例,中3例，优良率为80％。结论 此方法是治疗亚急性和陈旧性舟状骨骨折的有效措施,值得推广。
目的 探讨慢性甲状腺炎合并亚急性甲状腺炎患者的临床特征，明确其诊断方法，以减少临床误诊率。方法 回顾性分析2008年6月至2009年12月期间吉林大学中日联谊医院甲状腺外科行手术治疗的5例慢性甲状腺炎合并亚急性甲状腺炎患者的临床资料，包括病史、症状、体征、临床诊治过程、临床辅助检查结果（甲状腺功能检查、彩色多普勒超声检查、核素扫描等）的特点及病理特征。结果 5例患者中仅1例患者术前伴有间断发热和颈部疼痛病史，另外4例患者均无甲状腺炎的典型临床表现。5例患者临床诊治过程较长，病程迁延，平均病程6.8个月，药物对症治疗效果欠佳，症状及彩色多普勒超声检查结果无明显改善，均因术前不能除外恶变情况而行手术治疗。术中及术后病理检查结果均证实为慢性甲状腺炎合并亚急性甲状腺炎。结论 慢性甲状腺炎合并亚急性甲状腺炎临床诊断较困难，病程迁延，易被误诊，必要时可行穿刺病理学检查以明确诊断。
ObjectiveTo investigate the structure, ligand, and tissue distribution of galectin-3, the relationship of galectin3 with tumor and the expression of galectin-3 in several thyroid diseases. MethodsRelated articles were reviewed. ResultsGalectin-3 was expressed in normal and tumor cell that regulated cell growth, differentiation, adhesion, apoptosis, and angiogenesis, which participated invasion and metastasis of tumor. ConclusionGalectin-3 may be used to discriminate benign and malignant thyroid tumor.
ObjectiveTo observe systemic inflammatory response (SIR)of patients in different stages after the onset of aortic dissection (AD), and preliminarily explore a new staging system of AD based on SIR. MethodsFrom September 2011 to February 2012, 46 AD patients were admitted to the Department of Cardiovascular Surgery, West China Hospital of Sichuan University. There were 33 male and 13 female patients with their age ranging from 22 to 77 years (53.2±13.6 years). Blood samples were collected in 9 different periods after the onset of AD (0-12 hours (T1), 12-24 hours (T2), 24-48 hours (T3, 1-2 days), 48-96 hours (T4, 2-4 days), 96-168 hours (T5, 4-7 days), 168-336 hours (T6, 7-14 days), 336-720 hours (T7, 14-30 days), 720-1440 hours (T8, 30-60 days) and > 1 440 hours (T9, > days))to measure blood concentrations of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), C-reactive protein (CRP), endotoxin (ET), white blood cell (WBC)and neutrophils (Neut). SIR changes after the onset of AD were summarized. ResultsBlood concentrations of different inflammatory mediators were all significantly elevated within 14 days (T1-T6), significantly decreased in 14-60 days (T7-T8), and returned to normal range 60 days (T9)after the onset of AD. Peak levels of ET and TNF-α appeared in T1 with 263.42±29.98 pg/ml and 86.75±18.83 pg/ml respectively. Peak level of IL-6 appeared in T2 with 95.70±22.64 pg/ml. Peak level of CRP appeared in T5 with 123.74±54.78 mg/L. There was no obvious peak level of WBC or Neut. ConclusionDisease progression of AD can be divided into 3 stages including acute stage (within 14 days), subacute stage (14-60 days)and chronic stage ( > 60 days)based on the degree of SIR.